Gadolinium-based contrast agents and NSF: Evidence from animal experience
✍ Scribed by Martin A. Sieber; Thomas Steger-Hartmann; Philipp Lengsfeld; Hubertus Pietsch
- Publisher
- John Wiley and Sons
- Year
- 2009
- Tongue
- English
- Weight
- 927 KB
- Volume
- 30
- Category
- Article
- ISSN
- 1053-1807
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Nephrogenic systemic fibrosis (NSF) is a potentially severe systemic disease typically characterized by fibrosis of the skin and connective tissues. The etiology of NSF is still unknown but is likely to be multifactorial. Specific triggers under scientific evaluation have included surgery and/or the occurrence of thrombosis or other vascular injury, proinflammatory state, the administration of high doses of erythropoietin, and more recently the use of gadolinium‐based contrast agents (GBCAs). The aim of this review is to summarize knowledge regarding the pathogenesis of NSF and the potential role of GBCAs in its pathology, with a focus on animal experiments. The potential role of complex stability of GCBAs will be highlighted by results from several in vitro and in vivo experiments in rodent models of NSF. J. Magn. Reson. Imaging 2009;30:1268–1276. © 2009 Wiley‐Liss, Inc.